This program funds research in the areas of basic and clinical science, supporting projects designed to understand the molecular basis of the PA pathology and explore possible therapeutic avenues for the treatment of this condition.
PAF is particularly, but not exclusively, interested in the following areas of research:
- Improved treatment protocols including nutrition
- Development of chelating compounds for PA toxicity
- Risk factors for brain damage in PA
- Risk factors for development of pancreatitis in PA
- Risk factors for development of cardiomyopathy and/or arrhythmias in PA
- Disease modifiers in PA
- Development of new therapies and treatment
Deadline: October 1, 2020
